WW International (WW) said Tuesday it has partnered with Eli Lilly's (LLY) LillyDirect pharmacy provider, Gifthealth, to support WeightWatchers Clinic members in getting Zepbound single-dose vials.
This option will help self-pay patients who do not have insurance by offering a vial format for Zepbound if they have a valid prescription, the company said.
Gifthealth will handle prescription fulfillment, and WeightWatchers members will be able to track their prescriptions in real time through the WeightWatchers app, it added.
Shares of WW International were up over 60%, while Eli Lilly's stock was up about 0.7% in recent trading.
Price: 0.67, Change: +0.26, Percent Change: +63.19
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.